BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29098521)

  • 1. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
    Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
    Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumour cells in bone marrow of patients with uveal melanoma.
    Eide N; Hoifødt HK; Nesland JM; Faye RS; Qvale GA; Faber RT; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2013 Jun; 91(4):343-8. PubMed ID: 22632270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients.
    Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
    Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
    Flatmark K; Bjørnland K; Johannessen HO; Hegstad E; Rosales R; Hårklau L; Solhaug JH; Faye RS; Søreide O; Fodstad Ø;
    Clin Cancer Res; 2002 Feb; 8(2):444-9. PubMed ID: 11839662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
    Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.
    Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
    Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
    Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
    Demicheli R; Fornili M; Biganzoli E
    BMC Cancer; 2014 Jun; 14():392. PubMed ID: 24890689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine Needle Aspiration Biopsy in Uveal Melanoma: Technique, Complications, and Outcomes.
    Sellam A; Desjardins L; Barnhill R; Plancher C; Asselain B; Savignoni A; Pierron G; Cassoux N
    Am J Ophthalmol; 2016 Feb; 162():28-34.e1. PubMed ID: 26556006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.